141st APHA Annual Meeting

In This section

278065
MEPS-HC use and expenditure data

Sunday, November 3, 2013 : 8:45 AM - 9:30 AM

Jeffrey A. Rhoades, PhD , Center for Financing, Access, and Cost Trends, Agency for Healthcare Research and Quality, Rockville, MD
The proposed session will provide information regarding the details of the use, expenditure (both facility and separately billing doctors) and source of payment data, and other medical visit level information included on the eight MEPS public use event files produced annually: inpatient stays, emergency room, outpatient, office-based, and dental visits, home health care, prescribed medicines, and other medical expenses. Summary person level use and expenditure variables and the appropriate use of weights, and how the use of weights, are mandatory for generating nationally and regionally representative estimates with MEPS data will be presented. The editing and imputation methodology used to provide healthcare expenditures will be discussed. In addition, the nuances of flat fees and zero payment events will be discussed. Documentation and codebooks available for the public use files from the MEPS website will be demonstrated using Internet access. Participants will have the opportunity to have their specific research questions addressed through the use of live demonstration via the MEPS website.

Learning Areas:
Biostatistics, economics
Public health or related education
Public health or related public policy
Public health or related research
Social and behavioral sciences

Learning Objectives:
Identify eight different MEPS event files Describe person level expenditure variables.

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I have worked on the MEPS (and related surveys) survey for over 15 years and have served on the faculty of numerous workshops, have made over 25 MEPS related presentations at professional meetings and research organizations.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.